{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:31:38Z","timestamp":1790397098056,"version":"4.1.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamaneurol.2020.1995","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:43:17Z","timestamp":1594035797000},"page":"1233","source":"Crossref","is-referenced-by-count":61,"title":["Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source"],"prefix":"10.1001","volume":"77","author":[{"given":"Roland","family":"Veltkamp","sequence":"first","affiliation":[{"name":"Division of Brain Sciences, Imperial College London, London, United Kingdom"},{"name":"Department of Neurology, Alfried Krupp Krankenhaus, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesly A.","family":"Pearce","sequence":"additional","affiliation":[{"name":"currently a biostatistics consultant, St Catharines, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Korompoki","sequence":"additional","affiliation":[{"name":"Division of Brain Sciences, Imperial College London, London, United Kingdom"},{"name":"Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kasner","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Toni","sequence":"additional","affiliation":[{"name":"Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian F.","family":"Ameriso","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Fleni, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardi","family":"Mundl","sequence":"additional","affiliation":[{"name":"Bayer AG, Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgut","family":"Tatlisumak","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Institute of Neurosciences and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Hankey","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, Medical School, University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Lindgren","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Neurology, Lund University, Lund, Sweden"},{"name":"Department of Neurology, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Berkowitz","sequence":"additional","affiliation":[{"name":"Bayer, LLC, Whippany, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arauz","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Neurologia y Neurocirugia Manual Velasco Suarez, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serefnur","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Selcuk University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith W.","family":"Muir","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Psychology, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Chamorro","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Hospital Clinic of Barcelona, Institute Re\u00e7erca Biom\u00e8dica August Pi i Sunyer, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanjana","family":"Perera","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq","family":"Shuaib","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Rudilosso","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Hospital Clinic of Barcelona, Institute Re\u00e7erca Biom\u00e8dica August Pi i Sunyer, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Shoamanesh","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Hart","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"noi200043r1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9","key":"noi200043r2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation.","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"noi200043r3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct.","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"4","key":"noi200043r4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update.","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke"},{"issue":"9","key":"noi200043r5","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1161\/STROKEAHA.116.013713","article-title":"Risk stratification for recurrence and mortality in embolic stroke of undetermined source.","volume":"47","author":"Ntaios","year":"2016","journal-title":"Stroke"},{"issue":"23","key":"noi200043r6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"noi200043r7","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source.","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"noi200043r8","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1160\/TH17-08-0592","article-title":"The role of atrial fibrillation in patients with an embolic stroke of unknown source (ESUS).","volume":"117","author":"Wachter","year":"2017","journal-title":"Thromb Haemost"},{"issue":"4","key":"noi200043r9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1212\/WNL.0000000000007823","article-title":"Atrial fibrosis and its implications on a revised ESUS concept.","volume":"93","author":"Poli","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"noi200043r10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jamaneurol.2019.0591","article-title":"Tailoring the approach to embolic stroke of undetermined source: a review.","volume":"76","author":"Kamel","year":"2019","journal-title":"JAMA Neurol"},{"key":"noi200043r11","article-title":"Embolic strokes of undetermined source: theoretical construct or useful clinical tool?","author":"Tsivgoulis","journal-title":"Ther Adv Neurol Disord"},{"issue":"7","key":"noi200043r12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jamaneurol.2019.0617","article-title":"Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial.","volume":"76","author":"Healey","year":"2019","journal-title":"JAMA Neurol"},{"issue":"12","key":"noi200043r13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"noi200043r14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/2396987316663049","article-title":"Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: design of the NAVIGATE ESUS randomized trial.","volume":"1","author":"Hart","year":"2016","journal-title":"Eur Stroke J"},{"issue":"8","key":"noi200043r15","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.014","article-title":"Predictors of recurrent ischemic stroke in patients with embolic strokes of undetermined source and effects of rivaroxaban versus aspirin according to risk status: the NAVIGATE ESUS Trial.","volume":"28","author":"Hart","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"noi200043r16","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1161\/STROKEAHA.115.009334","article-title":"Embolic strokes of undetermined source in the Athens stroke registry: an outcome analysis.","volume":"46","author":"Ntaios","year":"2015","journal-title":"Stroke"},{"issue":"5","key":"noi200043r17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/1747493016641967","article-title":"Embolic strokes of undetermined source: prevalence and patient features in the ESUS global registry.","volume":"11","author":"Perera","year":"2016","journal-title":"Int J Stroke"},{"issue":"1","key":"noi200043r18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/STROKEAHA.114.007385","article-title":"Left-sided strokes are more often recognized than right-sided strokes: the Rotterdam study.","volume":"46","author":"Portegies","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"noi200043r19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3988\/jcn.2013.9.2.97","article-title":"Hemispheric differences in ischemic stroke: is left-hemisphere stroke more common?","volume":"9","author":"Hedna","year":"2013","journal-title":"J Clin Neurol"},{"issue":"1","key":"noi200043r20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/01.HYP.0000077983.66161.6F","article-title":"Is there a side predilection for cerebrovascular disease?","volume":"42","author":"Rodr\u00edguez Hern\u00e1ndez","year":"2003","journal-title":"Hypertension"},{"issue":"9","key":"noi200043r21","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1161\/STROKEAHA.119.025168","article-title":"Efficacy and safety of rivaroxaban versus aspirin in embolic stroke of undetermined source and carotid atherosclerosis.","volume":"50","author":"Ntaios","year":"2019","journal-title":"Stroke"},{"issue":"6","key":"noi200043r22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002012","article-title":"Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke.","volume":"4","author":"Gupta","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"noi200043r23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00259-015-3201-8","article-title":"High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET\/MR imaging.","volume":"43","author":"Hyafil","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"noi200043r24","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture.","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"noi200043r25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.117.029901","article-title":"D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study.","volume":"138","author":"Simes","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"noi200043r26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.115.016795","article-title":"Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate.","volume":"132","author":"Goldberger","year":"2015","journal-title":"Circulation"},{"issue":"23","key":"noi200043r27","doi-asserted-by":"publisher","first-page":"e2644","DOI":"10.1212\/WNL.0000000000007611","article-title":"Carotid plaques and detection of atrial fibrillation in embolic stroke of undetermined source.","volume":"92","author":"Ntaios","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"noi200043r28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/ene.2017.24.issue-5","article-title":"Non-obstructive carotid atherosclerosis and patent foramen ovale in young adults with cryptogenic stroke.","volume":"24","author":"Jaffre","year":"2017","journal-title":"Eur J Neurol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2767712\/jamaneurology_veltkamp_2020_oi_200043_1601489500.59071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T14:48:37Z","timestamp":1602514117000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2767712"}},"subtitle":["Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.1995","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}